Search our site

 

Editorial is subject to a small charge for use of colour images and may be edited to house style.
Write to us at: telecarenewsonline,
GMS Business Communications,
5 Argent Way, Sittingbourne, Kent, ME10 5AR Tel 01795 435913

Disclaimer & Copywright
All rights reserverd

No part maybe reproduced without the prior written permission of the publisher. Whilst every care is taken, prices and details are subject to change and the publisher can take no responsiblity for omissions or errors.

No responsibilty is taken for unsolicited submissions or the return of submitted items.

The Publisher gives no guarantee of actual publication date.
article added: 2017-06-05 13:38:05

Patient Monitoring Technology Secure £1.2M Funding

Funding from Deepbridge Capital, Scottish Enterprise and the Scottish Investment Bank will support development of pre-hospital care technology. Glasgow based medical technology developer Metix Limited, has announced that it has closed its initial R&D funding round of £1.2m, led by UK technology and life sciences investor Deepbridge Capital.

Headquartered in Glasgow, this funding also includes investment from Scottish Enterprise and the Scottish Investment Bank.

Metix was founded in 2013 to develop light-weight mobile vital signs monitors for use in the pre-hospital care environment. Metix’s core products provide market-leading, multi-parameter monitoring solutions for use by paramedic, military and humanitarian workers.

Metix operates internationally, having two offices (Glasgow and London), a sub-assembly factory in Mexico -all undergoing ISO compliance procedures. Metix’s research is supported by and has development agreements with the largest medical grade sensing companies in the world.

The funding will be utilised for further research and development as well as enhancing regulatory compliance. Metix expects to double its headcount in Glasgow with increased numbers particularly in technical and clinical validation.

Dr Julio Guerrero, Managing Director at Metix, commented;
“We are pleased to have received this initial R&D funding and are delighted to have the support of Deepbridge, Scottish Enterprise and the Scottish Investment Bank.

“This support demonstrates that the technology we are developing, and have already developed, is not only a good idea but is a commercially viable proposition which can make a real difference.

“Globally, pre-hospital critical care tech is at best ‘patchy’ and at worst is non-existent. We are committed to providing the technology to ensure that emergency responders anywhere in the world can have access to affordable, mobile and multi-parameter technology, which can be crucial in saving life and ensuring optimum care.”

Dr Savvas Neophytou, Head of Life Sciences at Deepbridge, added;
“Metix is further developing a device which has the potential to dramatically change the pre-hospital care sector. Whether used by paramedics, emergency responders, humanitarian workers or military; there are multiple uses for such an innovative piece of technology.

“We are delighted to be supporting Metix and look forward to working with them as they develop as a business and further enhance their remarkable technology. As always, we have to consider the medium-long term investment returns for our investors and to this end, we believe that Metix exhibits all the qualities associated with a successful company in the medical technology sector.”

For further information: www.metixmedical.co.uk



Disclaimer & Copyright All rights reserverd. No part maybe reproduced without the prior written permission of the publisher. Whilst every care is taken, prices and details are subject to change and the publisher can take no responsiblity for omissions or errors. No responsibilty is taken for unsolicited submissions or the return of submitted items. The Publisher gives no guarantee of actual publication date.